Therapeutic uses of Febuday 80

Febuday medicine has the main ingredient Febuxostat, which is an active ingredient that inhibits the enzyme xanthine oxidase (the enzyme that converts purine into uric acid), helping to reduce uric acid levels in the blood.
Thanks to the above use, Febuday 80 is indicated for the treatment of hyperuricemia when urate crystals have formed and/or arthritis caused by gout.

For the treatment of hyperuricemia in patients with gout, Febuday is recommended at a dose of 40mg or 80mg per day. For patients who do not achieve a serum uric acid index <60ml/dL after 2 weeks of Febuday 40mg, a switch to 80mg is recommended.
Note in some patient groups:
Patients with renal impairment: No dose adjustment is required in patients with mild to moderate renal impairment. The effectiveness and safety of the drug has not been fully evaluated in patients with severe renal impairment (creatinine clearance < 30ml/min); Hepatic impairment: The recommended dose in mild patients is 80 mg. There is currently no information on the effectiveness and safety of the drug in patients with moderate and severe hepatic impairment; Elderly: No dose adjustment is required. Febuday is not recommended for use in children, adolescents, and organ transplant patients. * Note: The above dosage is for reference only. The exact dose of Febuday depends on your condition and disease progression. For a safe dose, consult your doctor or healthcare professional.

In the process of taking Febuday to reduce uric acid, users may experience some of the following side effects:
Nausea; Joint pain, swelling or stiffness; skin rash; Chest tightness, difficulty breathing; Speak slowly; Dizziness, lightheadedness, fainting; Muscle weakness, numbness of hands/legs; Increase liver enzymes, damage liver function. In addition, the patient should stop the drug and seek the advice and support of the doctor if experiencing the following side effects:
Chest pain, feeling heavy; Pain spreading to the arm or shoulder area; Nausea, sweating, general weakness; sudden frostbite or weakness (especially on one side of the body); Sudden headache, confusion; problems with vision, voice, or balance; Abdominal pain, mild fever, loss of appetite; Dark urine, yellow clay stools, jaundice.

Contraindicated to use Febuday 80 with the following subjects:
Hypersensitivity to any ingredient of the drug; The patient is being treated with azathioprine, mercaptopurine or theophylline; In addition, caution should also be exercised when using Febuday in the following cases:
Acute gout attack; Patients with cardiovascular disease; Increased liver enzymes; Thyroid disorders; Intended use of drugs for children; Secondary hyperuricemia.

Febuday is not affected by food and antacids. Because the active ingredient Febuxostat in Febuday is a Xanthine oxidase (XO) inhibitor, co-administration of Febuday with substances metabolised by Xanthine oxidase (e.g. Theophylline, Mercaptopurine, Azathioprin) may increase plasma levels of Febuday. these drugs in plasma, leading to toxicity. Febuday 80 has the active ingredient Febuxostat, which is used in the treatment of uric acid reduction in people with gout. To use the drug safely and maximize the effectiveness of treatment, patients should carefully read the instructions or consult a doctor or pharmacist.
Follow Vinmec International General Hospital website to get more health, nutrition and beauty information to protect the health of yourself and your loved ones in your family.